Dror Ortho-Design, Inc.

Dror Ortho-Design, Inc. develops an AI-based orthodontic platform designed to correct smiles with less lifestyle disruption than traditional clear aligners. The company’s core product, ZSmile, uses a single smart aligner and pulsating air while the patient sleeps or stays at home, and it is positioned as a dentist-controlled alternative in the smile-correction market.

0.08

0.08

— Dror Ortho-Design, Inc.
%
Orthodontic treatment platform70% The ZSmile system and related orthodontic device platform used to move teeth discreetly during sleep or at home.
Legacy aligner system10% The earlier Aerodentis solution that remains part of the company’s technology history and product lineage.
Treatment software10% Software used to plan, monitor, and support dentist-controlled orthodontic treatment workflows.
Regulatory and IP-enabled commercialization10% Activities tied to FDA clearance, patent protection, and product readiness for market launch.

The company’s target customers are dental professionals, especially general practice dentists and orthodontists who...

  • General practice dentistsprimary

    They buy or recommend the platform to expand orthodontic services without relying only on orthodontists.

  • Orthodontistsprimary

    They use the system for smile correction treatment planning and patient monitoring.

  • Patients / consumersprimary

    They ultimately choose the treatment because the product promises discreet, lower-disruption smile correction.

  • Dental practices and clinicssecondary

    They adopt the platform to add orthodontic capability and differentiate their service offering.

The company is headquartered in the United States and reports in U.S. dollars, but its operating history includes...

  • •Headquartered in the United States
  • •Historical operating roots in Israel through predecessor Dror Ortho-Design Ltd.
  • •U.S. FDA clearance is central to commercialization
  • •No country-level revenue split disclosed in the filings
  • •Current exposure is mainly U.S. market development and launch

Management is focused on commercializing ZSmile, protecting the underlying intellectual property, and expanding the...

01
Commercialize ZSmileshort-term

The company needs a marketable product to move from development stage to revenue generation.

02
Broaden practitioner adoptionmedium-term

Selling through general dentists expands the reachable market beyond orthodontists.

03
Protect intellectual propertymedium-term

Patent and trade secret protection are important to defend the technology against larger competitors.

04
Secure financingshort-term

The company is loss-making and needs capital to continue development and commercialization.

The company is an early-stage medical device business with no current revenue, so its ability to continue as a going...

critical

Need for additional financing

The company is not generating revenues and must fund development and operations externally.

Scope
Going concern and dilution risk
Materiality
high
high

Failure to achieve market acceptance

The platform must convince dentists and patients to switch from established aligner solutions.

Scope
Commercial launch and adoption
Materiality
high
high

Competition from established aligner brands

Large competitors have stronger channels, brand recognition, and resources.

Scope
Align Technology, Dentsply Sirona (Byte), 3M, Straumann
Materiality
high
high

Product development and regulatory execution

The platform is a Class II medical device and commercialization depends on successful development and compliance.

Scope
FDA clearance, product quality, design changes
Materiality
high
medium

Business disruption and supply chain issues

Delays or shortages could interrupt R&D, manufacturing, and future deliveries.

Scope
Suppliers, internal systems, production readiness
Materiality
medium
Research and development expensed as incurred
Affects operating loss and comparability across periods
Going-concern assessment
Important for liquidity disclosure and investor risk assessment
Deferred revenue estimates
Could affect timing of revenue recognition and margins
No derivatives or off-balance-sheet arrangements
Limits exposure to fair value and hedge accounting issues

Vivos Therapeutics, Inc.

VVOS · Surgical & Medical Instruments & Apparatus

ZIMMER BIOMET HOLDINGS, INC.

ZBH · Orthopedic, Prosthetic & Surgical Appliances & Supplies

ALIGN TECHNOLOGY INC

ALGN · Orthopedic, Prosthetic & Surgical Appliances & Supplies

NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC · Surgical & Medical Instruments & Apparatus

zSpace, Inc.

ZSPC · Services-Prepackaged Software

IR-Med, Inc.

Electromedical & Electrotherapeutic Apparatus

: 28/04/2026